Agree. Tip off was that the one Serious AE was not reported in the initial report for Phase I study. That would never happen. The most important thing to look at in Phase I study is the Serious AEs. It would be totally central to the study to know if there were zero, or one, Serious AE. That tells me that the press release of 'zero AEs' followed up by new press release and hit pieces of 'one Serious AE' was all a set up.
That was my theory too. Some one with either shorts and/or options KNEW the numbers and KNEW it was going to be way over $7 by this time under normal circumstances. Their only plan of action was to put out pre-written bash articles to get the price as far from $7 as possible before this morning.